BOSTON (AP) — BOSTON (AP) — X4 Pharmaceuticals, Inc. (XFOR) on Tuesday reported a loss of $23.9 million in its fourth quarter.
On a per-share basis, the Boston-based company said it had a loss of 22 cents.
The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 36 cents per share.
The company posted revenue of $2.6 million in the period, which also topped Street forecasts. Three analysts surveyed by Zacks expected $1.7 million.
For the year, the company reported a loss of $79.2 million, or $1.87 per share. Revenue was reported as $35.1 million.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on XFOR at https://www.zacks.com/ap/XFOR
About the Author
Discover more from USA NEWS
Subscribe to get the latest posts sent to your email.
